Press Releases
Press Releases
Metabolix to Present Advances in Biopolymer Technology at ANTEC Conference
Metabolix Inc. an innovation-driven bioscience company focused on delivering sustainable solutions for plastics chemicals and energy today announced that its researchers will make technical presentations at the ANTEC Conference being held April 22-25 in Cincinnati Ohio. ...
Press Releases
Chemspec India 2013 brings together leading suppliers and buyers of fine and speciality chemicals in Mumbai
The ninth edition of Chemspec India - the only dedicated event in India for the fine and speciality chemicals community - concluded successfully at the Bombay Exhibition Centre in Goregaon, Mumbai on April 11 and 12. ...
Press Releases
Novasep discovers explosive properties of Togni reagent II
Novasep, a leading supplier of purification and global manufacturing solutions of synthetic molecules and biomolecules, today announces its R&D team has discovered and characterised the explosive properties of the Togni reagent II and intermediates at the Novasep Leverkusen...
Press Releases
BioFire Submits 510(k) Application to FDA for FilmArray® Blood Culture Identification Test
BioFire Diagnostics Inc. today announced that it has submitted the FilmArray Blood Culture Identification (BCID) Panel to the U.S. Food and Drug Administration (FDA) for 510(k) clearance. The submission comes after the successful completion...
Press Releases
Women take centre stage at ground breaking healthcare conference
Over 50% of the speakers are prominent females in the scientific healthcare field at the ‘World Research and Innovation Congress – Pioneers in Healthcare’ event, Steigenberger Grandhotel, Brussels, 5 and 6 June, 2013. Despite...
Press Releases
BioAlliance Pharma’s Sitavig® Receives Market Authorization in the US For the Treatment of Herpes Labialis
BioAlliance Pharma SA today announced the receipt of marketing authorization from the U.S. Food and Drug Administration (FDA) for Sitavig® in the treatment of recurring Herpes labialis marking the successful conclusion to the assessment procedure carried out by...
Press Releases
Eyevensys announces an equity investment by Boehringer Ingelheim Venture Fund
Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer that enables prolonged production of therapeutic proteins for the treatment of ocular disease, today announces an equity investment by the Boehringer Ingelheim Venture Fund (BIVF). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














